These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8886436)

  • 1. Principles of economic evaluation in cancer screening.
    Krahn M; Naglie G
    Cancer Treat Res; 1996; 86():25-40. PubMed ID: 8886436
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
    Parsonnet J; Harris RA; Hack HM; Owens DK
    Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial and economic evaluation.
    Jain S; Arora NK
    Indian J Pediatr; 2000 May; 67(5):363-8. PubMed ID: 10885210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filtering strategies in mass population screening for colorectal cancer: an economic evaluation.
    Walker A; Whynes DK
    Med Decis Making; 1992; 12(1):2-7. PubMed ID: 1538628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of prostate cancer screening: a systematic review.
    Lao C; Brown C; Rouse P; Edlin R; Lawrenson R
    Future Oncol; 2015; 11(3):467-77. PubMed ID: 25675126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The economic evaluation of the early diagnosis of breast carcinoma: a review of the literature].
    Vanara F
    Epidemiol Prev; 1992 Dec; 14(53):22-31. PubMed ID: 1341665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs.
    Glode AE; May MB
    Pharmacotherapy; 2017 Jan; 37(1):85-93. PubMed ID: 27862122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decisions about cancer screening - based on beliefs or facts?
    Schaefer C; Weißbach L
    Oncol Res Treat; 2014; 37 Suppl 3():4-5. PubMed ID: 25195825
    [No Abstract]   [Full Text] [Related]  

  • 10. PET challenges biopsy in fight to justify cost.
    Bieze J
    Diagn Imaging (San Franc); 1993 Aug; 15(8):53, 57-58. PubMed ID: 10146286
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the "Cancer Prevention Week" at Baden-Württemberg. An attempt at cost-benefit analysis].
    Goerttler K; Köhler CO; Wagner G; Wanzek L
    Med Welt; 1975 May; 26(20):961-71. PubMed ID: 1134319
    [No Abstract]   [Full Text] [Related]  

  • 12. [The cost of screening for breast and cervical cancer in France].
    Watt S
    Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity-Based Costing and Time-Driven Activity-Based Costing for Assessing the Costs of Cancer Prevention, Diagnosis, and Treatment: A Systematic Review of the Literature.
    Alves RJV; Etges APBDS; Neto GB; Polanczyk CA
    Value Health Reg Issues; 2018 Dec; 17():142-147. PubMed ID: 30149318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening in theory and in practice.
    Brawley OW; Kramer BS
    J Clin Oncol; 2005 Jan; 23(2):293-300. PubMed ID: 15637392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodological considerations in cost of prostate cancer studies: a systematic review.
    Molinier L; Bauvin E; Combescure C; Castelli C; Rebillard X; Soulié M; Daurès JP; Grosclaude P
    Value Health; 2008; 11(5):878-85. PubMed ID: 18494749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Care Costs and Clinical Trials.
    Kelly D; Brady C; Sui J; Cronin E; O'Hare D; Waldron J; O'Mahony D; Power D; Bambury RM; O'Reilly S
    Ir Med J; 2017 Apr; 110(4):557. PubMed ID: 28665096
    [No Abstract]   [Full Text] [Related]  

  • 18. Measuring the economic impact of perioperative total parenteral nutrition: principles and design.
    Eisenberg JM; Glick H; Hillman AL; Baron J; Finkler SA; Hershey JC; Lavizzo-Mourey R; Buzby GP
    Am J Clin Nutr; 1988 Feb; 47(2 Suppl):382-91. PubMed ID: 3124599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop.
    Neymark N; Kiebert W; Torfs K; Davies L; Fayers P; Hillner B; Gelber R; Guyatt G; Kind P; Machin D; Nord E; Osoba D; Revicki D; Schulman K; Simpson K
    Eur J Cancer; 1998 Aug; 34(9):1317-33. PubMed ID: 9849412
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.